What Will 2019 Bring for Medtech?
Healthcare is definitely changing, evident from several developments in 2018. While payers and providers have been working for some time to improve healthcare quality while reducing costs, this year we saw medtech respond with new solutions for improving care, expediting it, even bringing it to the home. New medical devices and diagnostics—particularly digital health technologies—are enabling patients to participate more in their own care. And providers are starting to put disrupters such as artificial intelligence and robotics into action in hopes of improving efficiency and outcomes.Such healthcare shifts are occurring at a time of regulatory change, given the European Union’s Medical Device Regulations (MDR) and FDA’s potential revamp of the 510(k) process.To predict how 2019 could unfold, MD+DI looked back over 2018’s progress. We also checked in with a few healthcare and medtech experts for their perspectives. We’d love to hear your predictions, too, so please comment below or email email@example.com.For a live discussion on what medtech can expect in 2019, MD+DI News Editor Amanda Pedersen moderates the panel, “What’s in Store for Medtech in 2019?” at MD&M West on February 5. The panel will include Mike Devereaux, partner and director of manufacturing, distribution, and plastics industry services, Mueller Prost; Bryan O'Byrne, chief of international affairs and trade policy, U.S. Small Business Administration; Yarmela Pavlovic, partner, Hogan Lovells; and Vicki Barbur, senior director, IP and technology commercialization, commercial business, Battelle.